5-cyclopropyl-1-(4-methylphenyl)-N-[1-[4-(2-oxopyrrolidin-1-yl)phenyl]ethyl]triazole-4-carboxamide
C25H27N5O2 — CID 86874566
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-cyclopropyl-1-(4-methylphenyl)-N-[1-[4-(2-oxopyrrolidin-1-yl)phenyl]ethyl]triazole-4-carboxamide
5-cyclopropyl-1-(4-methylphenyl)-N-[1-[4-(2-oxopyrrolidin-1-yl)phenyl]ethyl]triazole-4-carboxamide (PubChem CID 86874566) has the molecular formula C25H27N5O2 and a molecular weight of 429.52 g/mol. Its IUPAC name is 5-cyclopropyl-1-(4-methylphenyl)-N-[1-[4-(2-oxopyrrolidin-1-yl)phenyl]ethyl]triazole-4-carboxamide.
Molecular Properties
| Compound Name | 5-cyclopropyl-1-(4-methylphenyl)-N-[1-[4-(2-oxopyrrolidin-1-yl)phenyl]ethyl]triazole-4-carboxamide |
|---|---|
| PubChem CID | 86874566 |
| Molecular Formula | C25H27N5O2 |
| Molecular Weight | 429.52 g/mol |
| Exact Mass | 429.22 |
| IUPAC Name | 5-cyclopropyl-1-(4-methylphenyl)-N-[1-[4-(2-oxopyrrolidin-1-yl)phenyl]ethyl]triazole-4-carboxamide |
| SMILES | Cc1ccc(-n2nnc(C(=O)NC(C)c3ccc(N4CCCC4=O)cc3)c2C2CC2)cc1 |
| InChI | InChI=1S/C25H27N5O2/c1-16-5-11-21(12-6-16)30-24(19-7-8-19)23(27-28-30)25(32)26-17(2)18-9-13-20(14-10-18)29-15-3-4-22(29)31/h5-6,9-14,17,19H,3-4,7-8,15H2,1-2H3,(H,26,32) |
| InChIKey | VCWOMQBDZFDKEG-UHFFFAOYSA-N |
| XLogP | 4.07 |
| TPSA | 80.12 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 429.52 |
| LogP ≤ 5 | 4.07 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 86874566 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.